231 related articles for article (PubMed ID: 31401794)
1. Factors associated with systolic hypertension in peritoneal dialysis patients.
Vongsanim S; Davenport A
J Nephrol; 2020 Apr; 33(2):365-370. PubMed ID: 31401794
[TBL] [Abstract][Full Text] [Related]
2. Comparison of sodium removal in peritoneal dialysis patients treated by continuous ambulatory and automated peritoneal dialysis.
Maharjan SRS; Davenport A
J Nephrol; 2019 Dec; 32(6):1011-1019. PubMed ID: 31502219
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal sodium removal compared to glucose absorption in peritoneal dialysis patients treated by continuous ambulatory peritoneal dialysis and automated peritoneal dialysis with and without a daytime exchange.
Tangwonglert T; Davenport A
Ther Apher Dial; 2021 Oct; 25(5):654-662. PubMed ID: 33403730
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal Protein Losses Depend on More Than Just Peritoneal Dialysis Modality and Peritoneal Membrane Transporter Status.
Yoowannakul S; Harris LS; Davenport A
Ther Apher Dial; 2018 Apr; 22(2):171-177. PubMed ID: 29314721
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure, volume, and sodium control in an automated peritoneal dialysis population.
Boudville NC; Cordy P; Millman K; Fairbairn L; Sharma A; Lindsay R; Blake PG
Perit Dial Int; 2007; 27(5):537-43. PubMed ID: 17704444
[TBL] [Abstract][Full Text] [Related]
6. Aortic Pulse Wave Velocity in Peritoneal Dialysis Patients Is Not Simply Associated with Extracellular Water Expansion.
Tangvoraphonkchai K; Davenport A
Kidney Blood Press Res; 2019; 44(6):1423-1431. PubMed ID: 31715600
[TBL] [Abstract][Full Text] [Related]
7. Benefits of a continuous ambulatory peritoneal dialysis (CAPD) technique with one icodextrin-containing and two biocompatible glucose-containing dialysates for preservation of residual renal function and biocompatibility in incident CAPD patients.
Yoon HE; Chang YK; Shin SJ; Choi BS; Kim BS; Park CW; Song HC; Yoon SA; Jin DC; Kim YS
J Korean Med Sci; 2014 Sep; 29(9):1217-25. PubMed ID: 25246739
[TBL] [Abstract][Full Text] [Related]
8. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study.
Konings CJ; Kooman JP; Schonck M; Gladziwa U; Wirtz J; van den Wall Bake AW; Gerlag PG; Hoorntje SJ; Wolters J; van der Sande FM; Leunissen KM
Kidney Int; 2003 Apr; 63(4):1556-63. PubMed ID: 12631373
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal sodium mass removal in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis: influence on blood pressure control.
Ortega O; Gallar P; Carreño A; Gutierrez M; Rodriguez I; Oliet A; Vigil A; Gimenez E
Am J Nephrol; 2001; 21(3):189-93. PubMed ID: 11423687
[TBL] [Abstract][Full Text] [Related]
10. Sodium removal and peritoneal dialysis modalities: no differences with optimal prescription of icodextrin.
Fourtounas C; Dousdampanis P; Hardalias A; Vlachojannis JG
Artif Organs; 2013 Jul; 37(7):E107-13. PubMed ID: 23461737
[TBL] [Abstract][Full Text] [Related]
11. The effect of glucose absorption from peritoneal dialysates on changes in lipid profiles in prevalent peritoneal dialysis patients.
Law S; Davenport A
Perit Dial Int; 2021 Jan; 41(1):115-117. PubMed ID: 32037957
[TBL] [Abstract][Full Text] [Related]
12. Comparison of volume overload with cycler-assisted versus continuous ambulatory peritoneal dialysis.
Davison SN; Jhangri GS; Jindal K; Pannu N
Clin J Am Soc Nephrol; 2009 Jun; 4(6):1044-50. PubMed ID: 19406971
[TBL] [Abstract][Full Text] [Related]
13. Calcium balance in peritoneal dialysis patients treated by continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD) cyclers.
Davenport A
J Nephrol; 2023 Sep; 36(7):1867-1876. PubMed ID: 36862284
[TBL] [Abstract][Full Text] [Related]
14. Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectrical impedance analysis.
Woodrow G; Oldroyd B; Stables G; Gibson J; Turney JH; Brownjohn AM
Nephrol Dial Transplant; 2000 Jun; 15(6):862-6. PubMed ID: 10831642
[TBL] [Abstract][Full Text] [Related]
15. Fluid state and blood pressure control: no differences between APD and CAPD.
Cnossen TT; Konings CJ; Fagel WJ; van der Sande FM; van Geel K; Leunissen KM; Kooman JP
ASAIO J; 2012; 58(2):132-6. PubMed ID: 22370683
[TBL] [Abstract][Full Text] [Related]
16. Volume-Based Peritoneal Dialysis Prescription Guide to Achieve Adequacy Targets.
Akonur A; Firanek CA; Gellens ME; Hutchcraft AM; Kathuria P; Sloand JA
Perit Dial Int; 2016; 36(2):188-95. PubMed ID: 26293841
[TBL] [Abstract][Full Text] [Related]
17. Extracellular volume expansion in peritoneal dialysis patients.
Fan S; Sayed RH; Davenport A
Int J Artif Organs; 2012 May; 35(5):338-45. PubMed ID: 22466994
[TBL] [Abstract][Full Text] [Related]
18. Differences in predicting glucose absorption from peritoneal dialysate compared to measured absorption in peritoneal dialysis patients treated by continuous ambulatory peritoneal dialysis and ambulatory peritoneal dialysis cyclers.
Tangwonglert T; Davenport A
Int J Artif Organs; 2020 Jul; 43(7):461-467. PubMed ID: 31960740
[TBL] [Abstract][Full Text] [Related]
19. Impact of Diabetes on Extracellular Volume Status in Patients Initiating Peritoneal Dialysis.
Udo A; Goodlad C; Davenport A
Am J Nephrol; 2017; 46(1):18-25. PubMed ID: 28564640
[TBL] [Abstract][Full Text] [Related]
20. Routine Monitoring of Sodium and Phosphorus Removal in Peritoneal Dialysis (PD) Patients Treated with Continuous Ambulatory PD (CAPD), Automated PD (APD) or Combined CAPD+APD.
Moor V; Wagner R; Sayer M; Petsch M; Rueb S; Häring HU; Heyne N; Artunc F
Kidney Blood Press Res; 2017; 42(2):257-266. PubMed ID: 28531904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
